menu
    • menu

    Company profile for Baylor College of Medicine

    NEW Drugs in Dev: 31
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Baylor College of Medicine is committed to being a national leader in advancing human health through the integration of patient care, research, education and community service. We offer the opportunity to work in a challenging and stimulating environment with outstanding career opportunities and excellent benefits.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Baylor College of MedicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Baylor Plaza, Houston, Texas 77030
    Telephone
    Telephone
    (713)798-4951
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bcm.edu/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Texas Children's Researcher Wins Alzheimer's Grant
    Texas Children's Researcher Wins Alzheimer's Grant

    25 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/texas-childrens-researcher-awarded-grant-to-advance-new-ways-to-prevent-and-treat-alzheimers-disease-302724902.html

    PR NEWSWIRE
    25 Mar 2026
    Share Share
    Fortitude Has Faith Glue Degraders Can Beat ADC Resistance
    Fortitude Has Faith Glue Degraders Can Beat ADC Resistance

    26 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fortitude-has-faith-molecular-glue-degraders-can-overcome-adc-resistance

    FIERCE BIOTECH
    26 Jan 2026
    Share Share
    GMA Spotlights Baylor's MAR-T Pancreatic Cancer Study
    GMA Spotlights Baylor's MAR-T Pancreatic Cancer Study

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225492/0/en/Good-Morning-America-Features-Baylor-College-of-Medicine-Pancreatic-Cancer-Study-Utilizing-Marker-Therapeutics-MAR-T-Cell-Technology.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Baylor College Of Medicine Releases Positive Results
    Baylor College Of Medicine Releases Positive Results

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212598/0/en/Baylor-College-of-Medicine-Publishes-Promising-Safety-and-Efficacy-Results-of-Multi-Antigen-Targeted-T-Cells-in-Patients-with-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Inductive Bio Secures $21M To Enhance AI Drug Toxicity Models
    Inductive Bio Secures $21M To Enhance AI Drug Toxicity Models

    08 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inductive-bio-announces-an-up-to-21m-award-to-develop-ai-drug-toxicity-models-that-improve-drug-safety-assessment-with-leading-academic-and-biopharmaceutical-organizations-302634574.html

    PR NEWSWIRE
    08 Dec 2025
    Share Share
    Baylor Secures DoD $5m Grant for Gene Therapy to Target Osteoarthritis
    Baylor Secures DoD $5m Grant for Gene Therapy to Target Osteoarthritis

    14 Jun 2022

    // TRIALSITENEWS

    https://www.trialsitenews.com/a/baylor-secures-dod-5m-grant-for-gene-therapy-to-target-osteoarthritis-b9b7357e

    TRIALSITENEWS
    14 Jun 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search